Ruth O'Regan
14PUBLICATIONS
67CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Jun 23, 2023
A review of treatment options in HER2-low breast cancer and proposed treatment sequencing algorithm.Arya Mariam Roy, Vasanthan Muthusamy Kumarasamy, Ajay Dhakal
|May 19, 2023
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial.Kevin Kalinsky, Melissa K Accordino, Codruta Chiuzan
|May 12, 2023
Margetuximab in HER2-positive metastatic breast cancer.William J Gradishar, Ruth O'Regan, Mothaffar F Rimawi
|Apr 09, 2022
A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782).Ticiana A Leal, Marina N Sharifi, Nancy Chan
|Feb 24, 2022
Improving Outcomes for High-Risk Hormone Receptor-Positive Breast Cancer With CDK Inhibition.David Hicks, Ruth M O'Regan
Pageof 3
Frequent Collaborators
3 joint publications
Marina N Sharifi
2 joint publications
Jane Lowe Meisel
2 joint publications
Kari B Wisinski
2 joint publications
William J Gradishar
1 joint publications
Amy Harrington
1 joint publications
Christina M Scribano
1 joint publications
Jun Wan
1 joint publications
Karla Esbona
1 joint publications
Shuang G Zhao
1 joint publications
Amber Lasek